Matches in SemOpenAlex for { <https://semopenalex.org/work/W1987993522> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W1987993522 endingPage "322" @default.
- W1987993522 startingPage "319" @default.
- W1987993522 abstract "Iron deficiency is common in haemodialysis patients and adequate supplementation by the oral or parenteral route has been limited by drug side-effects, absorption, and cost. Intermittent doses of intravenous iron dextran complex are recommended in patients with inadequate iron stores despite maximal tolerated oral dose. We conducted a prospective study with economic analysis of a regular maintenance intravenous iron regimen in this group of patients.Fifty patients comprising one-half of our haemodialysis population required intravenous iron treatment, i.e. they failed to achieve an arbitrary goal serum ferritin 100 microg/l despite maximal tolerated oral iron dose. After a loading dose of intravenous iron dextran complex (IV-FeD) based on Van Wyck's nomogram (400+/-300 mg) they received a maintenance dose of 100mg IV-FeD once every 2 weeks. Initial goal serum ferritin was set at 100-200 microg/l. If no increase in haemoglobin was achieved at this level, transferrin saturation was measured to assess bioavailable iron, and when less than 20%, goal serum ferritin was increased to 200-300 microg/l. Recombinant human erythropoietin (rHuEpo) was used where needed to maintain haemoglobin in the 9.5-10.5 g/l range only if ferritin requirements were met. Results. Mean haemoglobin rose from 87.7+/-12.1 to 100.3+/-13.1 g/l (P<0.001, Cl 7.7-17.9) at mean follow-up of 6 months (range 3-15 months). In patients on rHuEpo, dose per patient was reduced from 96+/-59 u/kg per week to 63+/-41 u/kg per week, representing a 35% dose reduction (P<0.05, Cl 1-65). An annual cost reduction of $3166 CDN was projected; however, in the first year this is offset by the cost of the loading dose of IV-FeD required at the beginning of treatment. No adverse reactions were encountered.Iron deficiency is very common in our haemodialysis population, especially in those patients receiving rHuEpo. A carefully monitored regimen of maintenance parenteral iron is a safe, effective, and economically favourable means of iron supplementation in patients with insufficient iron stores on maximum tolerated oral supplements." @default.
- W1987993522 created "2016-06-24" @default.
- W1987993522 creator A5001052872 @default.
- W1987993522 creator A5026870372 @default.
- W1987993522 creator A5063770690 @default.
- W1987993522 creator A5090109455 @default.
- W1987993522 date "1996-02-01" @default.
- W1987993522 modified "2023-10-07" @default.
- W1987993522 title "Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patients" @default.
- W1987993522 doi "https://doi.org/10.1093/oxfordjournals.ndt.a027260" @default.
- W1987993522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8671786" @default.
- W1987993522 hasPublicationYear "1996" @default.
- W1987993522 type Work @default.
- W1987993522 sameAs 1987993522 @default.
- W1987993522 citedByCount "76" @default.
- W1987993522 countsByYear W19879935222012 @default.
- W1987993522 countsByYear W19879935222015 @default.
- W1987993522 countsByYear W19879935222018 @default.
- W1987993522 crossrefType "journal-article" @default.
- W1987993522 hasAuthorship W1987993522A5001052872 @default.
- W1987993522 hasAuthorship W1987993522A5026870372 @default.
- W1987993522 hasAuthorship W1987993522A5063770690 @default.
- W1987993522 hasAuthorship W1987993522A5090109455 @default.
- W1987993522 hasConcept C126322002 @default.
- W1987993522 hasConcept C141071460 @default.
- W1987993522 hasConcept C153852466 @default.
- W1987993522 hasConcept C2777417653 @default.
- W1987993522 hasConcept C2778248108 @default.
- W1987993522 hasConcept C2778319317 @default.
- W1987993522 hasConcept C2778534260 @default.
- W1987993522 hasConcept C2781413609 @default.
- W1987993522 hasConcept C27924281 @default.
- W1987993522 hasConcept C2908647359 @default.
- W1987993522 hasConcept C71924100 @default.
- W1987993522 hasConcept C90924648 @default.
- W1987993522 hasConcept C99454951 @default.
- W1987993522 hasConceptScore W1987993522C126322002 @default.
- W1987993522 hasConceptScore W1987993522C141071460 @default.
- W1987993522 hasConceptScore W1987993522C153852466 @default.
- W1987993522 hasConceptScore W1987993522C2777417653 @default.
- W1987993522 hasConceptScore W1987993522C2778248108 @default.
- W1987993522 hasConceptScore W1987993522C2778319317 @default.
- W1987993522 hasConceptScore W1987993522C2778534260 @default.
- W1987993522 hasConceptScore W1987993522C2781413609 @default.
- W1987993522 hasConceptScore W1987993522C27924281 @default.
- W1987993522 hasConceptScore W1987993522C2908647359 @default.
- W1987993522 hasConceptScore W1987993522C71924100 @default.
- W1987993522 hasConceptScore W1987993522C90924648 @default.
- W1987993522 hasConceptScore W1987993522C99454951 @default.
- W1987993522 hasIssue "2" @default.
- W1987993522 hasLocation W19879935221 @default.
- W1987993522 hasLocation W19879935222 @default.
- W1987993522 hasOpenAccess W1987993522 @default.
- W1987993522 hasPrimaryLocation W19879935221 @default.
- W1987993522 hasRelatedWork W2054251683 @default.
- W1987993522 hasRelatedWork W2134296716 @default.
- W1987993522 hasRelatedWork W2397469723 @default.
- W1987993522 hasRelatedWork W2461210988 @default.
- W1987993522 hasRelatedWork W2473288707 @default.
- W1987993522 hasRelatedWork W2801217032 @default.
- W1987993522 hasRelatedWork W2977632627 @default.
- W1987993522 hasRelatedWork W3081197250 @default.
- W1987993522 hasRelatedWork W3082809595 @default.
- W1987993522 hasRelatedWork W4384376845 @default.
- W1987993522 hasVolume "11" @default.
- W1987993522 isParatext "false" @default.
- W1987993522 isRetracted "false" @default.
- W1987993522 magId "1987993522" @default.
- W1987993522 workType "article" @default.